These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 17161371

  • 21. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair.
    Callebaut I, Mornon JP.
    FEBS Lett; 1997 Jan 02; 400(1):25-30. PubMed ID: 9000507
    [Abstract] [Full Text] [Related]

  • 22. Characterisation of the BRCT domains of the breast cancer susceptibility gene product BRCA1.
    Ekblad CM, Wilkinson HR, Schymkowitz JW, Rousseau F, Freund SM, Itzhaki LS.
    J Mol Biol; 2002 Jul 12; 320(3):431-42. PubMed ID: 12096901
    [Abstract] [Full Text] [Related]

  • 23. Binding of Rad51 and other peptide sequences to a promiscuous, highly electrostatic binding site in p53.
    Friedler A, Veprintsev DB, Rutherford T, von Glos KI, Fersht AR.
    J Biol Chem; 2005 Mar 04; 280(9):8051-9. PubMed ID: 15611070
    [Abstract] [Full Text] [Related]

  • 24. Solution structure, backbone dynamics, and association behavior of the C-terminal BRCT domain from the breast cancer-associated protein BRCA1.
    Gaiser OJ, Ball LJ, Schmieder P, Leitner D, Strauss H, Wahl M, Kühne R, Oschkinat H, Heinemann U.
    Biochemistry; 2004 Dec 28; 43(51):15983-95. PubMed ID: 15609993
    [Abstract] [Full Text] [Related]

  • 25. An investigation into 53BP1 complex formation.
    Roche KC, Lowndes NF.
    Adv Exp Med Biol; 2007 Dec 28; 604():47-57. PubMed ID: 17695720
    [Abstract] [Full Text] [Related]

  • 26. Structural consequences of a cancer-causing BRCA1-BRCT missense mutation.
    Williams RS, Glover JN.
    J Biol Chem; 2003 Jan 24; 278(4):2630-5. PubMed ID: 12427738
    [Abstract] [Full Text] [Related]

  • 27. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.
    Williams RS, Green R, Glover JN.
    Nat Struct Biol; 2001 Oct 24; 8(10):838-42. PubMed ID: 11573086
    [Abstract] [Full Text] [Related]

  • 28. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
    Williams RS, Lee MS, Hau DD, Glover JN.
    Nat Struct Mol Biol; 2004 Jun 24; 11(6):519-25. PubMed ID: 15133503
    [Abstract] [Full Text] [Related]

  • 29. Cancer predisposing mutations in BRCT domains.
    di Masi A, Gullotta F, Cappadonna V, Leboffe L, Ascenzi P.
    IUBMB Life; 2011 Jul 24; 63(7):503-12. PubMed ID: 21698754
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. BRCT domains: easy as one, two, three.
    Leung CC, Glover JN.
    Cell Cycle; 2011 Aug 01; 10(15):2461-70. PubMed ID: 21734457
    [Abstract] [Full Text] [Related]

  • 32. Structure of an XRCC1 BRCT domain: a new protein-protein interaction module.
    Zhang X, Moréra S, Bates PA, Whitehead PC, Coffer AI, Hainbucher K, Nash RA, Sternberg MJ, Lindahl T, Freemont PS.
    EMBO J; 1998 Nov 02; 17(21):6404-11. PubMed ID: 9799248
    [Abstract] [Full Text] [Related]

  • 33. Structural insight into p53 recognition by the 53BP1 tandem Tudor domain.
    Roy S, Musselman CA, Kachirskaia I, Hayashi R, Glass KC, Nix JC, Gozani O, Appella E, Kutateladze TG.
    J Mol Biol; 2010 May 14; 398(4):489-96. PubMed ID: 20307547
    [Abstract] [Full Text] [Related]

  • 34. Structure-activity relationship studies to probe the phosphoprotein binding site on the carboxy terminal domains of the breast cancer susceptibility gene 1.
    Yuan Z, Kumar EA, Kizhake S, Natarajan A.
    J Med Chem; 2011 Jun 23; 54(12):4264-8. PubMed ID: 21574625
    [Abstract] [Full Text] [Related]

  • 35. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling.
    Shiozaki EN, Gu L, Yan N, Shi Y.
    Mol Cell; 2004 May 07; 14(3):405-12. PubMed ID: 15125843
    [Abstract] [Full Text] [Related]

  • 36. Structural plasticity of methyllysine recognition by the tandem tudor domain of 53BP1.
    Tong Q, Cui G, Botuyan MV, Rothbart SB, Hayashi R, Musselman CA, Singh N, Appella E, Strahl BD, Mer G, Kutateladze TG.
    Structure; 2015 Feb 03; 23(2):312-21. PubMed ID: 25579814
    [Abstract] [Full Text] [Related]

  • 37. Role for 53BP1 Tudor domain recognition of p53 dimethylated at lysine 382 in DNA damage signaling.
    Kachirskaia I, Shi X, Yamaguchi H, Tanoue K, Wen H, Wang EW, Appella E, Gozani O.
    J Biol Chem; 2008 Dec 12; 283(50):34660-6. PubMed ID: 18840612
    [Abstract] [Full Text] [Related]

  • 38. Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BP1, and 53BP2.
    Thukral SK, Blain GC, Chang KK, Fields S.
    Mol Cell Biol; 1994 Dec 12; 14(12):8315-21. PubMed ID: 7969167
    [Abstract] [Full Text] [Related]

  • 39. Kinetic analysis of interaction of BRCA1 tandem breast cancer c-terminal domains with phosphorylated peptides reveals two binding conformations.
    Nominé Y, Botuyan MV, Bajzer Z, Owen WG, Caride AJ, Wasielewski E, Mer G.
    Biochemistry; 2008 Sep 16; 47(37):9866-79. PubMed ID: 18717574
    [Abstract] [Full Text] [Related]

  • 40. Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage.
    Anderson L, Henderson C, Adachi Y.
    Mol Cell Biol; 2001 Mar 16; 21(5):1719-29. PubMed ID: 11238909
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.